SCHEMBL4028445

SCHEMBL4028445

c1ccc(C(c2ccccc2)(c2ccccc2)c2nc3ccccc3[nH]2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 2/20 0.61
NPC1 O15118 6/20 0.50
RAB9A P51151 6/20 0.50
ALDH1A1 P00352 5/20 0.50
KDM4E B2RXH2 4/20 0.50
PKM P14618 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
ABCB11 O95342 1/20 0.50
TP53 P04637 1/20 0.50
HSD17B10 Q99714 1/20 0.50
GAA P10253 2/20 0.48
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
HSP90AA1 P07900 1/20 0.47
HPGD P15428 1/20 0.47
MASP2 O00187 1/20 0.47
NUDT1 P36639 1/20 0.47
AOC3 Q16853 1/20 0.47
HDAC6 Q9UBN7 1/20 0.44
POLB P06746 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6755353 0.85 NPSR1 (0.61) NPSR1NPC1RAB9AALDH1A1KDM4E
SCHEMBL5212881 0.80 NPSR1 (0.40) NPSR1NPC1RAB9AALDH1A1KDM4E
SCHEMBL5720453 0.78 NPSR1 (0.68) NPSR1NPC1RAB9AALDH1A1KDM4E
SCHEMBL229852 0.78 NPSR1 (0.68) NPSR1NPC1RAB9AALDH1A1KDM4E
SCHEMBL5169413 0.78 NPSR1 (0.53) NPSR1NPC1RAB9AALDH1A1KDM4E
SCHEMBL10295 0.76 NPSR1 (1.00) NPSR1NPC1RAB9AALDH1A1KDM4E
SCHEMBL30633367 0.76 NPSR1 (0.66) NPSR1NPC1RAB9AALDH1A1KDM4E
SCHEMBL4374246 0.76 NPSR1 (0.78) NPSR1NPC1RAB9AALDH1A1KDM4E
SCHEMBL29353981 0.76 NPSR1 (1.00) NPSR1NPC1RAB9AALDH1A1KDM4E
SCHEMBL13401355 0.76 NPSR1 (0.66) NPSR1NPC1RAB9AALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2049481-A2 NOVEL COMPOUNDS AS ANTAGONISTS OR INVERSE AGONISTS FOR OPIOID RECEPTORS SmithKline Beecham Corporation (US) 2009-04-22 EP disclosed
WO-2008021851-A2 NOVEL COMPOUNDS AS ANTAGONISTS OR INVERSE AGONISTS FOR OPIOID RECEPTORS SMITHKLINE BEECHAM CORPORATION (US) 2008-02-21 WO disclosed
US-6712262-B2 BENZIMIDAZOLE AND IODINE COMPOUNDS TAMURAKAKEN CORPORATION (JP) 2004-03-30 US disclosed